Release Date: 18/01/23 18:00 Summary: Notification of cessation of securities - BRB Price Sensitive: No Download Document 22.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%